YVONNE SOCORRO MANALO (MD) – Hematology & Oncology Physician, NPI 1619956596
Hematology & Oncology Physician
Main info
Doctor Profile
Profile Insights
NPPES metrics only — not quality of care.
1,006 HEMATOLOGY/ONCOLOGY in TX
Provider Addresses for YVONNE SOCORRO MANALO (MD)
PO BOX 81346
CORPUS CHRISTI, TX 784681346
Phone: (361) 887-0067
Fax: (361) 883-1484
Type: Mailing
1625 RODD FIELD RD STE 100
CORPUS CHRISTI, TX 784124926
Phone: (361) 887-0067
Fax: (361) 887-9453
Type: Location
1625, Rodd Field Road, Corpus Christi, Nueces County, Texas, 78412, United States
SUITE C
CORPUS CHRISTI, TX 784124926
Phone: (361) 887-0067
Fax: (361) 887-1484
Type: Location
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 301 Open Payments records for all available years, with a total value of $6,697.
Total Amount is formed as General ($6,697) + Research ($0) + Ownership ($0) = $6,697.
Last reported payment date: 2024-12-20 • Largest payer in this snapshot: E.R. Squibb & Sons, L.L.C. ($718).
Total Amount
$6,697
General + Research + Ownership
Payments
301
Total payment records
General Amount
$6,697
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-12-20
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| E.R. Squibb & Sons, L.L.C. | $718 |
| Merck Sharp & Dohme LLC | $519 |
| PFIZER INC. | $405 |
| AstraZeneca Pharmaceuticals LP | $403 |
| Novartis Pharmaceuticals Corporation | $260 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
PECOS enrollment status
Participating (accepts Medicare assignment)
Enrollment effective: 2010-02-17
PECOS data refreshed: 2026-05-27
Medicare revalidation (CMS due date list)
Due date not assigned yet
CMS is tracking this Medicare enrollment for revalidation, but has not published a due date.
Enrollment records
1
Earliest due date
Not assigned (TBD)
CMS data updated
2026-06-01
Revalidation progress
- Medicare enrolled
- On CMS revalidation list
- Due date assigned
- Revalidate in PECOS
CMS enrollment records
| Enrollment ID | Type | Specialty | State | Due date |
|---|---|---|---|---|
| I20100217000239 | I | Hematology/Oncology | TX | TBD |
What to do next
- No action required while the due date shows TBD.
- Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
- Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| Q5110 | Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 91,620 | 17 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 13,600 | 12 | $0 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 4,276 | 34 | $0 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 3,541 | 31 | $0 |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 830 | 45 | $0 |
Insurance plans in this area (ZIP 78468)
Loading plans...
Provider's Procedures
| Specialty | Practice State | HCPCS Code | Description | Service Count | Beneficiary Count |
|---|---|---|---|---|---|
| HEMATOLOGY/ONCOLOGY | TX | 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | 484 | 39 |
| HEMATOLOGY/ONCOLOGY | TX | 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 88 | 21 |
| HEMATOLOGY/ONCOLOGY | TX | 96415 | Infusion of chemotherapy into a vein | 110 | 20 |
Group practice members
| Name | Specialty | State |
|---|---|---|
| H E M A T O L O G Y/ O N C O L O G Y | TX | |
| Radiation Oncology | TX | |
| H E M A T O L O G Y/ O N C O L O G Y | TX | |
| H E M A T O L O G Y/ O N C O L O G Y | TX | |
| Nurse Practitioner | TX |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.